Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05906758 · ClinicalTrials.gov registry record · Phase 3
Ultra-Low Contrast Angiography in AKI
A Phase 3 study of Acute Kidney Injury, sponsored by Tulane University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 32
- Enrollment target
- 2
- Study locations
NCT05906758 is a Phase 3 study of Acute Kidney Injury that is actively recruiting participants, run by Tulane University. The registered enrollment target is 32 participants, below the 2,331-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05906758, a Phase 3 study of Acute Kidney Injury, is actively recruiting participants, sponsored by Tulane University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 32 participants
- Enrollment target
- 2
- Study locations
Study Summary
The aim of this study is to evaluate the safety of ultra-low contrast coronary angiography in patients with pre-existing acute kidney injury.
Conditions Studied
Interventions
- PROCEDURE Angiography
Study Locations (2)
Louisiana
- Tulane University Medical Center - New Orleans
- University Medical Center - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2025-09-05 |
| Est. Completion | 2026-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05906758
The ClinicalTrials.gov registry entry for NCT05906758 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,331-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (99% lower). The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Kidney Injury appearing as the primary indexed condition, and to 1 intervention - of which Angiography is the first listed.
NCT05906758 reports 2 study locations spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT05906758 about?
NCT05906758 is a clinical study titled "Ultra-Low Contrast Angiography in AKI". The aim of this study is to evaluate the safety of ultra-low contrast coronary angiography in patients with pre-existing acute kidney injury.
What is the current status of trial NCT05906758?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 32 participants. The study started on 2025-09-05. Estimated completion is 2026-12.
What conditions does trial NCT05906758 study?
This clinical trial studies the following conditions: Acute Kidney Injury.
What interventions are being tested in trial NCT05906758?
The interventions under investigation include: Angiography (PROCEDURE).
Who is sponsoring clinical trial NCT05906758?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05906758 being conducted?
This trial has 2 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Melatonin for Prevention of Kidney Injury
RECRUITING · Phase 3
-
SAfety of Regional Citrate Anticoagulation (SARCA Study)
RECRUITING · Phase 3
-
Acute Normovolemic Hemodilution in Complex Cardiac Surgery
COMPLETED · Phase 3
-
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
RECRUITING
-
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
RECRUITING
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.